Research Committee. 2.2.1 Establishment and Functions of RC. ---------------------------------
Research Committee. Warner and LeukoSite will each appoint up to 4 representatives to a research committee (the "Research Committee"), which will oversee the pre-clinical aspects of the Collaboration; except that such responsibilities will pass to the Development Committee in the case of a Warner-LeukoSite Product, to Warner in the case of a Warner Product and to LeukoSite in the case of a LeukoSite Product. The Warner representatives on such committee will together have only one vote and the LeukoSite members on such committee will together have only one vote. The Research Committee will meet quarterly, or more frequently if mutually agreed, and will report to the Management Committee. Warner's and LeukoSite's initial representatives to the Research Committee will be appointed by each of them promptly after the Effective Date. The Research Committee will be responsible for recommending compounds to be designated Development Candidates. All actions taken and decisions made by the Research Committee will be by unanimous agreement. The Management Committee will resolve disputes among the members of the Research Committee. A party may change any of its appointments to the Research Committee at any time upon giving written notice to the other party.
Research Committee. A research committee has been established by the parties as provided below and will be responsible for the planning and monitoring of the Research Plan (“Research Committee” or “RC”). In particular, the activities of the RC shall include:
Research Committee. 6 2.3 Use of Taisho Compound Library........................................ 6 2.4
Research Committee. (a) The Research Committee shall meet quarterly, or as otherwise agreed by the parties, alternating between the location of Focal and of the Developing Party, or at such locations as the parties agree. At its meetings, the Research Committee will (i) monitor the progress of the Research Program toward its objectives, and (ii) review and approve the Research Plan and Budget, pursuant to this Article 3. The host party's lead representative shall chair meetings of the Research Committee and shall be responsible for preparing the meeting agendas and minutes.
Research Committee. Promptly after the Effective Date, the parties will form a Research Committee (“RC”) comprised of four (4) members, with an equal number of representatives of each of Sequenom and P&G (two (2) members each). One (1) member of the RC shall be selected to act as the chairperson of the RC, with each chairperson acting for a term of twelve (12) months. The chairperson shall be selected alternately by Sequenom and P&G, and P&G shall designate the first chairperson. The RC shall determine the specific goals for the Research Program, shall manage the ongoing research conducted under the Research Program, and shall monitor the progress and results of such work. All decisions of the RC shall require unanimous approval, with the representatives of Sequenom on the RC collectively having one vote and the representatives of P&G on the RC collectively having one vote. The RC shall meet no less than once per quarter at such intervals and at such time and place as agreed upon by the
Research Committee. The RESEARCH COMMITTEE shall be comprised of appropriate representatives of both PARTIES, initially consisting of [***] representatives from each of NEKTAR AL and XXXXXX. Each PARTY shall appoint a RESEARCH PLAN team leader (and other key contacts, as necessary) to serve as principal RESEARCH COMMITTEE liaisons for the PARTIES. Employees of each PARTY who are not on the RESEARCH COMMITTEE may attend meetings of the RESEARCH COMMITTEE, as required to further the research and development of POTENTIAL PRODUCTS and COMMERCIAL PRODUCTS. The initial team leader and PARTY representatives are:
Research Committee. A Research Committee will be created to manage each Research Program.
Research Committee. The Parties shall form a joint research committee initially consisting of two (2) representatives designated by each Party (the "Research Committee"). The initial Research Committee representatives shall be [***] and [***] representing Cytokinetics and [***] and [***] representing Portola. By mutual written agreement, the Parties may each add an equal number of representatives to the Research Committee in response to the Parties needing any additional expertise to perform their activities *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Research Committee. The parties shall establish a Research Committee ------------------ ("RC") which shall be in existence for the Term of this Agreement, to oversee, review and coordinate the conduct of the Research Program. The responsibilities of the RC shall include without limitation:
